Back Login for AI Analysis

    XBIT (STOCKS)

    XBiotech Inc

    $2.370000
    -0.050000 (-2.07%)
    Prev close: $2.420000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Sushma Shivaswamy
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $73.78M
    Employees
    92
    P/E (TTM)
    -2.48
    P/B (TTM)
    0.43
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Sep 2025)
    Nonoperating Income/Loss $5.64M
    Research and Development $29.85M
    Operating Income/Loss -$34.68M
    Income/Loss From Continuing Operations After Tax -$29.16M
    Income/Loss From Continuing Operations Before Tax -$29.04M
    Income Tax Expense/Benefit $118.00K
    Net Income/Loss -$29.16M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$29.16M
    Net Income/Loss Available To Common Stockholders, Basic -$29.16M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$0.95
    Basic Average Shares 30,489,533
    Assets $172.42M
    Current Assets $148.95M
    Noncurrent Assets $23.47M
    Fixed Assets $23.47M
    Liabilities $5.34M
    Current Liabilities $3.57M
    Accounts Payable $1.04M
    Other Current Liabilities $2.52M
    Noncurrent Liabilities $1.78M
    Equity $167.08M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $167.08M
    Liabilities And Equity $172.42M
    Net Cash Flow From Operating Activities -$23.51M
    Net Cash Flow From Operating Activities, Continuing -$23.51M
    Net Cash Flow From Investing Activities -$339.00K
    Net Cash Flow From Investing Activities, Continuing -$339.00K
    Net Cash Flow From Financing Activities -$9.97M
    Net Cash Flow From Financing Activities, Continuing -$9.97M
    Net Cash Flow -$39.34M
    Net Cash Flow, Continuing -$33.81M
    Comprehensive Income/Loss -$29.16M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$29.16M
    Other Comprehensive Income/Loss -$38.53M